Exuma Biotech Company
EXUMA Biotech is a clinical-stage biotechnology company that focuses on discovering and developing CAR-T cell products for solid tumors.
Total Funding:
107000000
Headquarters:
Grand Cayman, Midland, Cayman Islands
Funding Status:
Early Stage Venture
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series B
Last Funding Date:
2021-12-21
Investors Number:
7
Founded Date:
2015-01-01
Industry:
CAR-T